Cure Pharmaceutical Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
14
- Stock Symbol
-
AVRW
- Investments
-
5
- Share Price
-
$0.02
- (As of Wednesday Closing)
Cure Pharmaceutical General Information
Description
Avenir Wellness Solutions Inc is a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on approximately 15 patents, offers several immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The company sells its product under the brand names Seratopical, Seratopical Revolution, SeraLabs, and Nutri-Strips.
Contact Information
Website
www.curepharmaceutical.comCorporate Office
- 1620 Beacon Place
- Oxnard, CA 93033
- United States
Corporate Office
- 1620 Beacon Place
- Oxnard, CA 93033
- United States
Cure Pharmaceutical Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.02 | $0.02 | $0.02 - $0.13 | $1.56M | 78M | 20.6K | -$0.06 |
Cure Pharmaceutical Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 12,674 | 13,760 | 17,531 | 35,699 |
| Revenue | 2,864 | 4,347 | 4,896 | 6,078 |
| EBITDA | (4,217) | (3,254) | (16,506) | (5,588) |
| Net Income | (4,440) | (3,444) | (25,509) | (13,193) |
| Total Assets | 1,030 | 2,607 | 6,854 | 40,574 |
| Total Debt | 8,900 | 8,283 | 10,061 | 13,872 |
Cure Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cure Pharmaceutical Comparisons
Industry
Financing
Details
000000
0000 0
Cure Pharmaceutical Competitors (45)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intelgenx Technologies | Corporation | Saint-Laurent, Canada | 00 | 000.00 | 000000&0 | |
| Rani Therapeutics | Formerly VC-backed | San Jose, CA | 000 | 00000 | 000000000 | 00000 |
| Oramed Pharmaceuticals | Corporation | New York, NY | 00 | 0000 | 000000 - 000 | 0000 |
| Eagle Pharmaceuticals | Formerly VC-backed | Woodcliff Lake, NJ | 000 | 00000 | 000000000 00 | 00000 |
| Corium International | Private Equity-Backed | Boston, MA | 000 | 00000 | 000000000000 |
Cure Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cure Pharmaceutical Patents
Cure Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200268646-A1 | Multi-layered high dosage dissolvable film for oral administration | Active | 18-Jun-2017 | 000000000 | |
| US-20130108560-A1 | Chemical treatments for the disruption of dental plaque biofilms and related methods | Inactive | 01-Nov-2011 | 00000000 | 0 |
| US-20070087036-A1 | Edible film for transmucosal delivery of nutritional supplements | Inactive | 03-May-2005 | 000000000 | 00 |
| US-20040191302-A1 | Fluidized bed dry air suspension; static spray gun atomizing; preventing agglomeration; solvent free | Inactive | 28-Mar-2003 | 0000000000 | 00 |
| US-20040131662-A1 | Film and powder matrix layer; multilayer thin film; antipyretics | Inactive | 15-Nov-2002 | A61K9/0056 | 00 |
Cure Pharmaceutical Executive Team (10)
| Name | Title | Board Seat |
|---|---|---|
| Mark Udell | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | |
| Michael Redard | Chief Financial Officer | |
| Jessica Rousset | Chief Operating Officer, Operations | |
| Robert Davidson | Chief Executive Officer & Board Member | |
| Seema Kumar | Chief Executive Officer |
Cure Pharmaceutical Board Members (16)
| Name | Representing | Role | Since |
|---|---|---|---|
| Anya Goldin JD | Self | Board Member | 000 0000 |
| Gene Salkind MD | Self | Board Member | 000 0000 |
| John Bell | Self | Board Member | 000 0000 |
| Joshua Held | Self | Board Member | 000 0000 |
| Lauren Chung Ph.D | Self | Board Member | 000 0000 |
Cure Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cure Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cure Pharmaceutical Investments & Acquisitions (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sera Labs | 02-Oct-2020 | 0000000000 | 000.00 | Pharmaceuticals | 000000 00 |
| Coeptis Therapeutics Holdings | 12-Nov-2019 | 000000000 | 00000 | Pharmaceuticals | |
| Chemistry Holdings | 14-May-2019 | 0000000000 | 000.00 | Drug Delivery | 000000 00 |
| Therapix Biosciences (Non-Pain Assets) | 11-Jul-2018 | 000000000 | Buildings and Property | 000000 00 | |
| CURE Pharmaceutical Holding | 07-Nov-2016 | Merger/Acquisition | Paper/Soft Products |
Cure Pharmaceutical Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Sera Labs | Pharmaceuticals | Lewiston, ME | 0000 |
Cure Pharmaceutical Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Coeptis Therapeutics Holdings | 12-Nov-2019 | 000000000 | 00000 | Completed |
|
Cure Pharmaceutical FAQs
-
When was Cure Pharmaceutical founded?
Cure Pharmaceutical was founded in 2011.
-
Who is the CEO of Cure Pharmaceutical?
Robert Davidson and Seema Kumar are the CEOs of Cure Pharmaceutical.
-
Where is Cure Pharmaceutical headquartered?
Cure Pharmaceutical is headquartered in Oxnard, CA.
-
What is the size of Cure Pharmaceutical?
Cure Pharmaceutical has 14 total employees.
-
What industry is Cure Pharmaceutical in?
Cure Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Cure Pharmaceutical a private or public company?
Cure Pharmaceutical is a Public company.
-
What is Cure Pharmaceutical’s stock symbol?
The ticker symbol for Cure Pharmaceutical is AVRW.
-
What is the current stock price of Cure Pharmaceutical?
As of 11-Sep-2024 the stock price of Cure Pharmaceutical is $0.02.
-
What is the current market cap of Cure Pharmaceutical?
The current market capitalization of Cure Pharmaceutical is $1.56M.
-
What is Cure Pharmaceutical’s current revenue?
The trailing twelve month revenue for Cure Pharmaceutical is $2.86M.
-
Who are Cure Pharmaceutical’s competitors?
Intelgenx Technologies, Rani Therapeutics, Oramed Pharmaceuticals, Eagle Pharmaceuticals, and Corium International are some of the 45 competitors of Cure Pharmaceutical.
-
What is Cure Pharmaceutical’s annual earnings per share (EPS)?
Cure Pharmaceutical’s EPS for 12 months was -$0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
